Application
of radioimmunoassay procedures to the measurement of steroid hormones has enhanced the ease and rapidity of these determinations. Assay sensitivity permits measurements for small amounts of plasma or serum; however, lack of antibody specificity usually necessitates extraction and purification of Individual steroids before quantitation. Many times, purification procedures involve time-consuming steps for each steroid, and artifact "blanks" are introduced during the process. We report a relatively simple, rapid procedure for specific determination of unconjugated estrone (E1),1 estradiol (E2), estriol (E3), progesterone (P4), and 17-hydroxyprogesterone (170H-P) in a single sample of serum or plasma. 'Nonstandard abbreviations used: E1, estrone; E2, estradiol; E3, estriol; P4, progesterone;
Materials and Methods

Extraction and Purification
170H-P, 17a-hydroxyprogesterone (trival name for 17a-hydroxypregn-4-ene-3,20-dione); BSA, bovine serum albumin.
Received Nov. 28, 1972; accepted Dec. 4, 1972. beled steroid2 in 0.1 ml of phosphate buffered saline, was added for each steroid to be assayed. The serum was extracted twice with 6.0 ml of cold diethyl ether in a mechanical partition extractor.3 The combined ether extracts were evaporated under a stream of nitrogen in a water bath at 40#{176}C.
The ether extracts were partially purified by column chromatography adapted from the procedure of Mikhail et al. (1) with use of Sephadex LH-204 in a benzene-methanol (85:15 by vol) solvent system. Glass columns (0.9 cm i.d.) were packed to a gel height of 30 cm and fitted with Teflon tubing adaptors. Glass reservoirs were attached to each column to permit 100-150 ml elution capacity with no more than 10 cm of hydrostatic pressure above the gel bed. Effluent from each of 8-12 columns was pumped simultaneously to a modified fraction collector using a multiple-tube proportioning pump.5 Solvent-resistant tubing6 was used on the pump, connections to the pump, and to the fraction collector. Figure 1 shows the apparatus assembled for the simultaneous chromatography on 12 columns. Serum extracts were dissolved in 0.5 ml of column solvent and applied to the top of the gel bed. After the sample had entered the gel, the solvent reservoir was filled and the pump started. One milliliter fractions were routinely collected. Each column was precalibrated with 3H-or 14C-labeled steroids before fractionating unknown serum extracts. After elution, each steroid area was pooled, evaporated in a 13 x 100 mm tube, and the residue redissolved in 1.0 ml of column solvent. From this 1.0 ml, 0.1 ml was removed and transferred to a counting vial for recovery determination.
The remaining 0.9 ml was again evaporated for assay. When specific antibodies against P4 and (or) 170H-P were not available for assays, further chromatography of these steroid fractions from the benzene-methanol column was necessary for their specific determination.
In this instance, no recovery aliquot was taken from eluted areas containing P4 or 170H-P until the final step of purification.
Progesterone was, when necessary, further purified by applying the eluted fraction to a second 30 X 0.9 cm column of Sephadex LH-20 equilibrated with chloroform-heptane-ethanol (50:50:0.25 by vol) and fractionated according to the procedures outlined above. 170H-P was further purified by acetylation of the eluted fraction followed by rechromatography. It was acetylated by adding 0.3 ml of pyridine and 0.3 ml of acetic anhydride to the dried eluate and incubating for 1 h at 95#{176}C in a water bath. The sample was then evaporated under nitrogen, redissolved in 0.2 ml of benzene-methanol (85:15), and applied to a 0.3 X 15 cm column equilibrated with this solvent. Column chromatography was performed as before, except that 0.5 ml fractions were collected and pooled. All radiolabeled steroids were quantitated in a Nuclear-Chicago Mark I Scintillation Spectrometer, with use of a scintillation medium containing the following components:
(a) toluene (1 liter), (b) POPOP7 (60 mg), (c) PPOT (4.2 g), and (d) "Biosolv"8 (100 ml). gates-17fl-estradiol-BSA,9 1la-progesterone-BSA1#{176} and 170H-P-B5A11-were used in the assays described here. All antisera were produced by the same general procedure.
Antisera Production and Evaluation
One milligram of steroid conjugate was dissolved in 1.0 ml of saline, emulsified with 1.0 ml of Freund's complete adjuvant (Difco), and injected intradermally in 40 separate sites on the back of adult female rabbits. We repeated this procedure three times at 10-day intervals, after which we gave subcutaneous booster injections of 1.0 mg in saline at 14-21 day intervals. Blood was sampled from the rabbits 10 days after each immunization, and the serum was treated with "Rivanol"12 according to the method described by Abraham (2) . An aliquot of each treated serum was serially diluted in a pH 7.0 buffer (B-i) containing, per liter, 0.1 mole of phosphate, 0.15 mole of sodium chloride, 1 g of "Knox" gelatin, and 1 g of sodium azide. The titer of antibodies to a given steroid was determined by incubating 0.1 ml of the diluted antiserum with 30 pg of radiolabeled steroid in 0.1 ml of the above-described buffer. The incubation period and procedure for determination of binding ability are described below.
Assay Procedures
To the dried sample or standard'3 in 13 X 100 mm glass tubes, 0.1 ml of antiserum and 30 pg of labeled steroid in 0.1 ml, both in B-i buffer, were added. Tubes were incubated at 4#{176} for 2-16 h. The shorter time was adequate but the longer time was sometimes used for convenience.
The tubes were then transferred to a water bath at 4#{176}C and to each was added 0.1 ml of a mixture of (per liter): Knox gelatin, 5 g; phosphate, 0.1 mole; and 0.15 mole of sodium chloride (pH 7.0, buffer B-2). Immediately thereafter we added 1.0 ml of a mixture of, per liter, 2.5 g of charcoal and 0.25 g of dextran14 in B-i buffer (3). The tubes were mixed on a vortex-type mixer, transferred to prechilled carriers and centrifuged (1000 x g) for 10 mm at 4#{176} C. After centrifugation, the supernatant fluids were decanted into counting vials and 15.0 ml of scintillation medium (described above) was added.
All assays included, in addition to standard and unknown steroids, extracts of 2.0 ml distilled water (blanks) and chromatographed serum samples that had been previously assayed. Supernatant fluids of 917$-estradiol-BSA: A 17$ succinyl derivative coupled to BSA at the 17 position; a gift from the National Cancer Institute, Bethesda, Md.
'#{176}lla-progesterone-BSA:
A chlororcarbonate derivative of progesterone coupled to bovine serum albumin at the 11 position.
Obtained from Hi Laboratories, Whitmore Lake, Mich. 
with weighted linear regression analysis, according to the procedure described by Rodbard et al. (4) .
Results
Extraction and Purification
The extraction procedure described here consistently yielded 92-95% of the five steroids assayed. Extraction recoveries with 3H-labeled testosterone, deoxycorticosterone, and androstenedione indicated other steroids to be extracted with equal efficiency. Therefore, specific steroid determinations depended on chromatographic purification and (or) antibody specificity. Figure 2 shows the resolution during column chromatography of the five steroids assayed. The region of the eluate collected for measurement of P4, 170H-P, E1, E2, and E3 contained 95, 92, 92, 90, and 90% of the respective steroids applied to the column. Chromatography of other tritiated steroids indicated that several other hormones are eluted in the same areas as those being assayed; however, when relatively specific antibodies were used for assay, no further purification was used.
When specific antibodies were not available, rechromatography of the P4 and 170H-P regions adequately resolved these steroids for assay. P4 was partly resolved from steroids of similar polarity. Although androstenedione was not totally separated from P4, sufficient quantities of hormone for assay were obtained by collecting only the first half of the eluted P4. By using the recovery calculation, we determined the P4 content of the whole sample. After acetylation, the i7OH-P fraction was readily purified satisfactorily.
Average recovery of 17OH-P from 26 Shaded areas indicate fractions pooled for assay columns by the rechromatography procedure was 92%; the recovered 170H-P was essentially free of cross-reacting steroids.
Antibody Specificity
The specificity of anti-steroid antibodies determined the degree of purification necessary in the assays. We have never been able to obtain totally specific antibodies to ovarian steroids; however, their relative specificity has been high, as Table 1 illustrates. These data clearly indicate that the anti-E2 serum does not react significantly with any of the neutral steroids and that separation of the estrogens is the only purification required for adequate assay specificity.
Neutral steroids had a much higher cross-reactivity than the phenolic estrogens. The antisera used to obtain the data in Table 1 are the most specific for P4 and 17OH-P of those found from 236 bleedings of 56 rabbits. With these sera, no further chromatography after the first benzene-methanol column was needed. However, with less specific sera, further purification of P4 was necessary to remove cross-reacting androstenedione and to remove testosterone from the 170H-P region before the latter was assayed. The chromatographic procedures described above for further purification of P4 and 170H-P were satisfac- 213 tory for performing specific assays when nonspecific antisera were used. Anitbody titers for the sera described in Table 1  permitted them to be used at a final dilution of 1:40,000, 1:2000 and 1:2000 for E2, P4. and i7OH-P. respectively.
Factors Affecting Assay Performance
Several factors common to all the assays were evaluated for their effect on assay performance.
We tested the ability of the dextran-coated charcoal to adsorb unbound labeled steroids. Although a maximum of 45 pg of any labeled steroid was present in any assay tube, the amount of dextran-charcoal used consistently removed 97.99% of 200 pg of all tracer steroids tested.
Maintenance of a constant temperature during the incubation of antisera with tracer and unknown is important. Satisfactory assays were obtained at temperatures of 40, 22#{176}, or 37#{176}C. However, a fluctuation of ±4#{176}C during the assay procedure after incubation resulted in poor precision.
Variation in buffer pH between 6.9 and 7.6 did not alter the results.
Effects of solvent "blanks" on binding of steroid to the antibody were also studied. As much as 10.0 ml of the benzene-methanol solvent caused no significant (P <0.05) change in tracer binding or hormone displacement; however, if more than 4.0 ml of the chloroform-heptane-ethanol solvent was used in progesterone rechromatography, there was decreased binding of tracer steroids, so smaller volumes were used to contain the progesterone sample to be assayed. No assay response was obtained from distilled water extracts in any of the assay systems.
We tested the effects of adding labeled steroid to serum samples for recovery determination on the validity of each assay. Dose-response curves for various amounts of standard hormones were compared with curves in which antisera and identical standards were pre-incubated with 15 pg of tracer hormone. The curves were essentially congruent, and statistical analysis confirmed (P <0.01) that adding this amount of labeled tracer had no effect on the assays.
Assay Sensitivity and Precision
The sensitivity of assays was considered to be the amount of standard that produced a statistically significant (P <0.05) displacement of labeled hormone from the antibody. Precision was calculated from the portion of the dose-response lines between 10 and 90% displacement.
All three estrogens were assayed with the same antisera but with added labeled tracer corresponding to the specific estrogen to be assayed. For tritiated E1, the estrone assays had a sensitivity of 20 pg. The coefficient of variation (CV) for a single sample was 6.2% while the mean CV among 159 assays of the same serum sample was 18.2%. Figure 3a illustrates the dose response of E,, Responses in the E2 assay system are shown in Figure 3b . The sensitivity of this system was 10 pg for E2 and the intra-and inter-assay variation (162 assays) for a single sample was 5.4% and 14.7%, respectively. In the E3 system (Figure 3c ), the sensitivity was only 30 pg and the CV was 7.0% for a single sample and 19.6% among 128 assays of the same sample. Cross-reaction of E2 in the E3 assay system was greater than that of E3, with the same anti-E2 sera.
Dose-response curves for P4 and 170H-P are shown in Figure 4 . The average sensitivity of the P4 system, with an antiserum raised against P4-11-bovine serum albumin, was 12.0 pg; intra-assay variation was 6.0%. The CV among 204 assays of the same serum was 15.6%. In the 170H-P assay an anti-serum was used against 170H-P conjugated with bovine serum albumin at the 3 position. This assay system was sensitive to 15 pg, with an intraand inter-assay CV of 8.0% and 17.9% (104 assays), respectively.
Assay Specificity and Accuracy
To confirm the adequacy of the chromatographic procedure for resolving cross-reacting steroids, particularly the estrogens, we added known amounts of unlabeled steroids to a previously assayed serum and the serum was taken through the entire procedure. For example, when 50 pg of E2 was added to a serum containing 38 pg of E,, 46 pg of E2, and 25 pg of E3, and the mixture extracted, chromatographed, and 
Serum Steroid Concentrations
Mean concentrations of the five steroids assayed in human sera are shown in Table 2 . An example of ovarian hormone secretion pattern during a normal human menstrual cycle is illustrated in Figure 5 . Gonadotropin concentrations are also shown, as reference points during the cycle.
Discussion
Although numerous methods have been described for radioimmunoassay of ovarian steroids (1, 5-10), the procedure described here has some distinct advantages. Those investigators who wish to obtain an entire profile of ovarian secretion can do so with a single serum sample by the procedure described here. In addition, the semi-automatic apparatus for column chromatography permits one technician to assay 24 serum samples (120 determinations) during an 8-h working day. Many of these advantages are gained because of the high relative specificity of the antisera used. Because the need for chromatographic purification is diminished with more specific antisera, simplicity and speed of assays are enhanced.
Few assay procedures meet the ideal criteria of absolute specificity and accuracy, and exhaustive studies to demonstrate the reliability of our method were not conducted.
However, the data obtained ( urn'cc c'tvi.E pler assay systems, in which no chromatographic purification is required.
